<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nichols, Emma Hitt</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Jaff, Michael R.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Hypercholesteremia, Hypertension, and Antiplatelet Therapy in PAD</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2013-12-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">31-31</style></pages><abstract><style  face="normal" font="default" size="100%">Medical management of cardiovascular risk factors, such as hypercholesteremia, hypertension, and the use of antiplatelet therapy may improve patient outcomes for peripheral artery disease (PAD). This article discusses optimized medical therapy for patients with PAD.</style></abstract><number><style face="normal" font="default" size="100%">19</style></number><volume><style face="normal" font="default" size="100%">13</style></volume></record></records></xml>